Imperial College London
Dr Philippa C. May

Dr Philippa C. May

Faculty of Medicine, Department of Immunology and Inflammation

Visiting Researcher
 
 
 
//

Contact

 

philippa.may

 
 
//

Location

 

4N5Commonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Neviani:2013:10.1172/JCI68951,
author = {Neviani, P and Harb, JG and Oaks, JJ and Santhanam, R and Walker, CJ and Ellis, JJ and Ferenchak, G and Dorrance, AM and Paisie, CA and Eiring, AM and Ma, Y and Mao, HC and Zhang, B and Wunderlich, M and May, PC and Sun, C and Saddoughi, SA and Bielawski, J and Blum, W and Klisovic, RB and Solt, JA and Byrd, JC and Volinia, S and Cortes, J and Huettner, CS and Koschmieder, S and Holyoake, TL and Devine, S and Caligiuri, MA and Croce, CM and Garzon, R and Ogretmen, B and Arlinghaus, RB and Chen, C-S and Bittman, R and Hokland, P and Roy, D-C and Milojkovic, D and Apperley, J and Goldman, JM and Reid, A and Mulloy, JC and Bhatia, R and Marcucci, G and Perrotti, D},
doi = {10.1172/JCI68951},
journal = {JOURNAL OF CLINICAL INVESTIGATION},
pages = {4144--4157},
title = {PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells},
url = {http://dx.doi.org/10.1172/JCI68951},
volume = {123},
year = {2013}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Neviani,P
AU  - Harb,JG
AU  - Oaks,JJ
AU  - Santhanam,R
AU  - Walker,CJ
AU  - Ellis,JJ
AU  - Ferenchak,G
AU  - Dorrance,AM
AU  - Paisie,CA
AU  - Eiring,AM
AU  - Ma,Y
AU  - Mao,HC
AU  - Zhang,B
AU  - Wunderlich,M
AU  - May,PC
AU  - Sun,C
AU  - Saddoughi,SA
AU  - Bielawski,J
AU  - Blum,W
AU  - Klisovic,RB
AU  - Solt,JA
AU  - Byrd,JC
AU  - Volinia,S
AU  - Cortes,J
AU  - Huettner,CS
AU  - Koschmieder,S
AU  - Holyoake,TL
AU  - Devine,S
AU  - Caligiuri,MA
AU  - Croce,CM
AU  - Garzon,R
AU  - Ogretmen,B
AU  - Arlinghaus,RB
AU  - Chen,C-S
AU  - Bittman,R
AU  - Hokland,P
AU  - Roy,D-C
AU  - Milojkovic,D
AU  - Apperley,J
AU  - Goldman,JM
AU  - Reid,A
AU  - Mulloy,JC
AU  - Bhatia,R
AU  - Marcucci,G
AU  - Perrotti,D
DO  - 10.1172/JCI68951
EP  - 4157
PY  - 2013///
SN  - 0021-9738
SP  - 4144
TI  - PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells
T2  - JOURNAL OF CLINICAL INVESTIGATION
UR  - http://dx.doi.org/10.1172/JCI68951
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325443100012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL  - 123
ER  -
Download